Date Filed | Type | Description |
10/14/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/04/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| CHILDS JOHN W (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Disposed/sold 3,025,001 shares
@ $148.5, valued at
$449.2M
Disposed/sold 10,000 shares
@ $148.5, valued at
$1.5M
Disposed/sold 8,239 options to buy
@ $0 Disposed/sold 11,996 options to buy
@ $0 |
|
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Heffernan Michael Thomas (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Disposed/sold 3,320 options to buy
@ $0 Disposed/sold 8,239 options to buy
@ $0 Disposed/sold 11,996 options to buy
@ $0 Disposed/sold 26,200 options to buy
@ $0 |
|
10/03/2022 |
4
| GREGORY JULIA P (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Disposed/sold 8,239 options to buy
@ $0 Disposed/sold 11,996 options to buy
@ $0 Disposed/sold 18,000 options to buy
@ $0 |
|
10/03/2022 |
4
| JONES WILLIAM A JR (CCO-Migraine & Common Disease) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Disposed/sold 14,226 shares
@ $148.5, valued at
$2.1M
Disposed/sold 11,250 options to buy
@ $0 Disposed/sold 10,000 options to buy
@ $0 Disposed/sold 3,000 options to buy
@ $0 Disposed/sold 775 options to buy
@ $0 Disposed/sold 29,225 options to buy
@ $0 Disposed/sold 2,398 options to buy
@ $0 Disposed/sold 37,602 options to buy
@ $0 Disposed/sold 1,742 options to buy
@ $0 Disposed/sold 28,258 options to buy
@ $0 Disposed/sold 5,913 options to buy
@ $0 |
|
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| HUGIN ROBERT J (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Disposed/sold 2,900 shares
@ $148.5, valued at
$430.7k
Disposed/sold 3,417 options to buy
@ $0 Disposed/sold 8,239 options to buy
@ $0 Disposed/sold 11,996 options to buy
@ $0 Disposed/sold 18,948 options to buy
@ $0 |
|
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Bailey Gregory (Director) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Disposed/sold 2,583,658 shares
@ $148.5, valued at
$383.7M
Disposed/sold 8,239 options to buy
@ $0 Disposed/sold 11,996 options to buy
@ $0 Disposed/sold 18,000 options to buy
@ $0 |
|
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
8-K
| Quarterly results |
10/03/2022 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
10/03/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/03/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/03/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/03/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
09/29/2022 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits Interac... |
09/28/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
09/27/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
09/23/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
09/23/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
09/23/2022 |
8-K
| Other Events Interactive Data |
09/19/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
09/19/2022 |
424B7
| Form 424B7 - Prospectus [Rule 424(b)(7)]: |
09/19/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
|